Loomis Sayles & CO L P Moderna, Inc. Transaction History

Loomis Sayles & CO L P

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $10,902 - $14,768	-92 Reduced 67.15%	45 $5,000
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $11,802 - $17,140	87 Added 174.0%	137 $21,000
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $101,925 - $180,844	-861 Reduced 94.51%	50 $9,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $104,491 - $171,849	885 Added 3403.85%	911 $108,000
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $91,683 - $170,411	-725 Reduced 96.54%	26 $4,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $53,970 - $88,073	239 Added 46.68%	751 $191,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $67,901 - $148,247	-306 Reduced 37.41%	512 $197,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $8,833 - $15,978	-68 Reduced 7.67%	818 $192,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $76,644 - $130,557	702 Added 381.52%	886 $116,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $12,096 - $31,254	184 New	184 $19,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.